While the effectiveness of bariatric surgery in achieving diabetic remission in people with moderate to severe obesity is well established, the decision between surgical and non‐surgical treatment for patients with mild obesity remains unresolved. In order to achieve diabetic remission, we want to assess the effects of surgical and nonsurgical treatment for patients with a BMI of less than 35kg/m2. All of the obese and prediabetic individuals who were monitored at our tertiary centre and had BS are being evaluated in this retrospective observational analysis. Regardless of A1c, patients on antidiabetic medications were deemed to have diabetes. After applying the previously indicated exclusion criteria, all 689 patients with prediabetes were included in this study, with the exception of those with BS who had no A1c during the first year of follow‐up or who had undergone gastric band surgery. Bariatric surgery is superior to non‐surgical treatment for achieving diabetes remission in 7 included trials with 544 participants [OR 25.06, 95%CL 9.58‐65.54]. Significant decreases in HbA1c [MD ‐1.44, 95%CL (‐1.84)‐(‐1.04)] and FPG [MD ‐2.61, 95%CL (‐3.20)‐(‐2.20)] were more likely to occur after bariatric surgery. The BMI may decrease after bariatric surgery [MD ‐3.14, 95%CL (‐4.41)‐(‐1.88)], which is especially noticeable in Asians. In conclusion Bariatric surgery is more likely than nonsurgical treatment to result in diabetes remission and improved blood glucose control in people with type 2 diabetes whose BMI is less than 35kg/m2.
R. Aashish and M.K. Suresh. Long‐Term Outcomes of Bariatric Surgery on Type Diabetes Remission.
DOI: https://doi.org/10.36478/10.36478/makrjms.2024.11.153.157
URL: https://www.makhillpublications.co/view-article/1815-9346/10.36478/makrjms.2024.11.153.157